Impact of genetic analysis on Parkinson's disease research

Movement Disorders

Volumn 18, Issue SUPPL. 6, 2003, Pages

  Hardy, John ^a,b  

^a Laboratory of Membrane Biochemistry and Biophysics   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Genetics; Parkin; Parkinson's disease; Proteasone; Synuclein; Ubiquitin hydrolase

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE RECEPTOR STIMULATING AGENT; HYDROLASE; LEVODOPA; PARKIN; PROTEASOME; UBIQUITIN;

ARTICLE; GENETIC ANALYSIS; HUMAN; LABORATORY DIAGNOSIS; MEDICAL RESEARCH; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0141502277     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10569     Document Type: Article

References (17)

1. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the -synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
2. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392:605-608.
3. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003;299:256-259.
4. Leroy E, Boyer R, Auburger G. The ubiquitin pathway in Parkinson's disease. Nature 1998;395:451-452.
5. Gwinn-Hardy K. Genetics of parkinsonism. Mov Disord 2002;17: 645-656.
6. Hardy J, Cookson MR, Singleton A. Genes and parkinsonism. Lancet Neurology 2003;2:221-228.
7. Skipper L, Farrer M. Parkinson's genetics: molecular insights for the new millennium. Neurotoxicology 2002;23:503-514.
8. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1991;55:181-184.
9. Gwinn-Hardy K, Singleton A, O'Suilleabhain P, et al. Spinocerebellar ataxia type 3 phenotypically resembling Parkinson's disease in a black family. Arch Neurol 2001;58:296-299.
10. Gwinn-Hardy K, Chen JY, Liu HC, et al. Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology 2000;55: 800-805.
11. Burn DJ, McKeith IG. Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease. Mov Disord 2003;18(suppl. 6):S72-S79.
12. Muenter MD, Forno LS, Hornykiewicz O, et al. Hereditary form of parkinsonism-dementia. Ann Neurol 1998;43:768-781.
13. Abbas N, Lucking CB, Ricard S, et al. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Hum Mol Genet 1999;8:567-574.
14. Farrer M, Chan P, Chen R, et al. Lewy Bodies and parkinsonism in families with parkin mutations. Ann Neurol 2001;50:293-300.
15. Maraganore DM, Farrer MJ, Hardy JA, et al. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Neurology 1999;53:1858-1860.
16. Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, Vink L, Choi P, Wolozin B, Farrer M, Hardy J, Cookson MR. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron. 2002;36:1007-1019.
17. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998;67:425-479.